Related references
Note: Only part of the references are listed.JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4
Junhu Wan et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades
Taisuke Hoshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
Xiaoxiao Fan et al.
CANCER MEDICINE (2019)
Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma
Eman A. Toraih et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
Zhikun Liu et al.
BMC CANCER (2018)
Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
Fei Ji et al.
BMC CANCER (2018)
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
Chao-Qun Liu et al.
BRITISH JOURNAL OF CANCER (2018)
Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC
Yun Liu et al.
CANCER RESEARCH (2018)
LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis
Zhi-an Ling et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Hypermethylation of NF-kappa B-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis
Patrick Kwok Shing Ng et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma
Yingjun Liu et al.
EJSO (2018)
Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma
Rongchang Wang et al.
HUMAN PATHOLOGY (2018)
Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma
Min Shi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
Mingyu Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
Xian-Yang Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
An Tang et al.
RADIOLOGY (2018)
Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer
Koichi Sawaki et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
Shan-Ru Zuo et al.
JOURNAL OF CANCER (2018)
Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer
Dai Shimizu et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway
Yu Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma
Shaolong Li et al.
CANCER SCIENCE (2018)
SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation
Hongliang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment
Xiang-Yu Hu et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Reduced expression of Nrdp I predicts a poor prognosis in human hepatocellular carcinoma
Xian Shao et al.
ONCOTARGETS AND THERAPY (2018)
Expression of sushi domain containing two reflects the malignant potential of gastric cancer
Shinichi Umeda et al.
CANCER MEDICINE (2018)
Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma
Ping Li et al.
MEDICINE (2018)
KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma
Zhengchen Jiang et al.
ONCOTARGETS AND THERAPY (2018)
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting BcI2L10
Xiaodong Wang et al.
ONCOTARGETS AND THERAPY (2018)
MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion
Ying Ye et al.
OncoTargets and Therapy (2018)
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma
Hisateru Komatsu et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection
H. Fan et al.
ONCOGENE (2017)
The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
C. Cao et al.
ONCOGENE (2017)
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
Ya Cheng et al.
ONCOTARGETS AND THERAPY (2017)
MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway
Yun Jin et al.
EXPERIMENTAL CELL RESEARCH (2017)
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma
Jingyang He et al.
GENE (2017)
Calcium-Binding Protein 39 Promotes Hepatocellular Carcinoma Growth and Metastasis by Activating Extracellular Signal-Regulated Kinase Signaling Pathway
Lingxi Jiang et al.
HEPATOLOGY (2017)
Hepatic IFIT3 Predicts Interferon-α Therapeutic Response in Patients of Hepatocellular Carcinoma
Yingyun Yang et al.
HEPATOLOGY (2017)
Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma
Huanlin Wang et al.
HUMAN PATHOLOGY (2017)
MicroRNAs in the Diagnosis and Treatment of Cancer
Behzad Mansoori et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5
Yang Ke et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma
Yan Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
Dai Shimizu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis
Tianyu He et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway
Yaling Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma
Tian Lan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma
Deng Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment
Meili Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma
Soon Sun Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
Qiuran Xu et al.
MOLECULAR CANCER (2017)
Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
Jing Meng et al.
MOLECULAR CANCER (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1
Hui Zhang et al.
ONCOLOGY REPORTS (2017)
Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma
Mingming Fan et al.
ONCOLOGY REPORTS (2017)
EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy
Jintian Tang et al.
ONCOLOGY REPORTS (2017)
hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma
Sumadi Lukman Anwar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition
Yongfu Xu et al.
ONCOTARGETS AND THERAPY (2017)
An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma
Mitsuro Kanda et al.
ONCOTARGET (2017)
Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma
Sijie Cheng et al.
Oncotarget (2017)
MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer
Liwei Sun et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
Dai Shimizu et al.
SCIENTIFIC REPORTS (2017)
High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma
Yan-Yan Wang et al.
SCIENTIFIC REPORTS (2017)
Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker
Ka Yin Lui et al.
BMC CANCER (2017)
Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
Shinichi Umeda et al.
BMC CANCER (2017)
Vascular CXCR4 Expression Promotes Vessel Sprouting and Sensitivity to Sorafenib Treatment in Hepatocellular Carcinoma
Jing Xu et al.
CLINICAL CANCER RESEARCH (2017)
Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC
Jian-Hua Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway
Peijuan Chen et al.
CANCER SCIENCE (2017)
GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma
Sheng Zhang et al.
BMC CANCER (2017)
Management of hepatocellular in the United States
Ali A. Mokdad et al.
CHINESE CLINICAL ONCOLOGY (2017)
ERBB4 acts as a suppressor in the development of hepatocellular carcinoma
Yao Liu et al.
CARCINOGENESIS (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Molecular mechanisms of peritoneal dissemination in gastric cancer
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
J. Best et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2016)
NRAGE promotes the malignant phenotype of hepatocellular carcinoma
Dai Shimizu et al.
ONCOLOGY LETTERS (2016)
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
Le Qu et al.
NATURE COMMUNICATIONS (2016)
Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
Kazuhiro Ezaka et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma
Yuri Tanaka et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Recent advances in the molecular diagnostics of gastric cancer
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
Sheng-Chun Wang et al.
PLOS ONE (2014)
The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels
Chikako Shibata et al.
VIROLOGY (2014)
Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Kol Jia Yong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
Wei Zhuo et al.
CLINICAL CANCER RESEARCH (2012)
Regulatory Factor X1-induced Down-regulation of Transforming Growth Factor β2 Transcription in Human Neuroblastoma Cells
Chenzhuo Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET
Julia Kleylein-Sohn et al.
JOURNAL OF CELL SCIENCE (2012)
MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases
Beatrice M. Filippi et al.
EMBO JOURNAL (2011)
GPR155: Gene organization, multiple mRNA splice variants and expression in mouse central nervous system
Stefan Trifonov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2010)
Cancer gene discovery in hepatocellular carcinoma
Lars Zender et al.
JOURNAL OF HEPATOLOGY (2010)
Sall4 Regulates Cell Fate Decision in Fetal Hepatic Stem/Progenitor Cells
Tsunekazu Oikawa et al.
GASTROENTEROLOGY (2009)
Identification and characterization of novel human tissue-specific RFX transcription factors
Syed Aftab et al.
BMC EVOLUTIONARY BIOLOGY (2008)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial
Hui-Chuan Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma
DI Loukinov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
